+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ZOTA

Zota Healthcare Share Price

₹1,288.00 -18 (-1.38%)
25.98% Fall from 52W High

20 Nov, 2026 3:54 PM (IST)

Zota Healthcare live price: ₹1,288.00. It opened at ₹1,298 vs previous close ₹1,306; intraday high/low: ₹1,310/₹1,280. The 50 & 200 DMA stand at ₹1,269.50/₹1,259.90.

Zota Healthcare Performance

  • Today's Low
  • ₹1,280
  • Today's High
  • ₹1,310
  • 52 Week Low
  • ₹1,022
  • 52 Week High
  • ₹1,740
  • Open Price₹1,298
  • Previous Close₹1,306
  • Volume14,210
  • 50 DMA₹1,269.50
  • 100 DMA₹1,261.20
  • 200 DMA₹1,259.90

Zota Healthcare Chart

Investment Returns

  • Over 1 Month -5.29%
  • Over 3 Month + 19.62%
  • Over 6 Month + 7.1%
  • Over 1 Year -22.86%

Smart Investing Starts Here Start SIP with Zota Healthcare for Steady Growth!

Invest Now

Zota Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -39.5
  • PEG Ratio
  • 0.5
  • Market Cap Cr
  • 4,461
  • P/B Ratio
  • 6.9
  • Average True Range
  • 53.1
  • EPS
  • -32.6
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 6.9
  • RSI
  • 51.04
  • MFI
  • 60.02

Latest Stock News Updates

Zota Healthcare Results Earnings Call for Q3FY26

Conference Call with Zota Healthcare Management and Analysts on Q3FY26 Performance and Outlook. Listen to the <a href="https://youtu.be/ROScJ2t1xBI">full earnings transcript</a>. <br>

Zota Healthcare Results Earnings Call for Q2FY26

Conference Call with Zota Healthcare Management and Analysts on Q2FY26 Performance and Outlook. Listen to the <a href="https://youtu.be/_Lx2TU8AksI">full earnings transcript</a>. <br>

Zota Healthcare Financials

Zota Healthcare Technicals

EMA & SMA

Current Price
₹1,288.00
-18 (-1.38%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹1,284.50
  • 50 Day
  • ₹1,269.50
  • 100 Day
  • ₹1,261.20
  • 200 Day
  • ₹1,259.90

Resistance and Support

1292.67 Pivot Speed
  • R3 1,335.30
  • R2 1,322.70
  • R1 1,305.30
  • S1 1,275.30
  • S2 1,262.70
  • S3 1,245.30

Zota Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-28 Quarterly Results and Other business matters
2026-08-13 Quarterly Results & Others To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
2026-05-22 Audited Results, Dividend & Others To consider other business matters.
2026-02-04 Quarterly Results & Others To consider other business matters.
2025-10-17 Quarterly Results & Others To consider other business matters.
Date Purpose Remarks
2026-09-21 FINAL Re.0.00 Final Dividend of Re. 1 per equity share.
2025-09-22 FINAL Re.0.00 Final Dividend of Re. 1 per equity share
2024-09-21 FINAL Re.0.00 the final dividend at rate of 10% i.e Re. 1/- per share
View Zota Healthcare Dividend History Arrow

Zota Healthcare Shareholding Pattern

49.38%
36.4%
6.93%
6.92%
0.37%

About Zota Healthcare

Zota Health Care engaged in the business of as a drug development, manufacturing and marketing on retail as well as wholesale basis. The group caters to both domestic and international markets. Being a progressive Indian pharmaceutical company, it offers View More
  • NSE Symbol
  • ZOTA
  • BSE Symbol
  • ISIN
  • INE358U01012

Similar Stocks to Zota Healthcare

Zota Healthcare FAQs

Zota Healthcare share price is ₹1,288 As on 21 November, 2026 | 18:02

The Market Cap of Zota Healthcare is ₹4460.7 Cr As on 21 November, 2026 | 18:02

The P/E ratio of Zota Healthcare is -39.5 As on 21 November, 2026 | 18:02

The PB ratio of Zota Healthcare is 6.9 As on 21 November, 2026 | 18:02

The 52 week High & Low of Zota Healthcare is ₹1740/₹1022 respectively As on 21 November, 2026 | 18:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23